AT & S Austria Technologie & Systemtechnik (ATS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
14 May, 2026Executive summary
Achieved strong operating performance in a challenging environment, with significant cost optimization, customer diversification, and progress on major investments in Malaysia and Austria.
Sale of the Ansan/Korea plant provided a substantial one-off positive impact on EBITDA and net income.
Equity ratio increased and leverage reduced; no dividend proposed to preserve balance sheet strength and support future growth.
Efficiency program delivered €120 million in cost savings, with an additional €130 million targeted for the next year.
Financial highlights
Revenue for FY 2024/25 rose 3% year-over-year to €1,590–1,600 million; adjusted EBITDA increased 6% to €408 million, with a margin of 25.7–26%.
Net profit reached €90 million, up €126 million year-over-year; EPS at €1.86.
Sale of Ansan/Korea plant contributed €325 million to EBITDA and EBIT, €247 million to net income, and €6.37 to EPS.
Net CAPEX reduced by 52% to €415 million; operating free cash flow at -€489 million.
Equity ratio improved to 23.3% (up 2.6pp); net debt/EBITDA at 2.5.
Outlook and guidance
Q1 2025/26 revenue guidance is approximately €400 million, up 14% year-over-year, with EBITDA margin expected at 16% due to ramp-up costs.
Full-year guidance withheld due to market uncertainty, including U.S. tariffs and potential recession risks; midterm (FY 2026/27) guidance targets €2.1–2.4 billion revenue and 24–28% EBITDA margin.
Planned Q1 investments of €60–65 million, with slightly higher quarterly numbers expected by year-end.
Latest events from AT & S Austria Technologie & Systemtechnik
- Revenue and earnings fell, guidance lowered, cost-saving and asset sale measures ongoing.ATS
Q2 202515 May 2026 - Strong growth in high-end electronics and substrates, with AI and efficiency gains fueling expansion.ATS
Austrian Select Conference23 Apr 2026 - Revenue up 10% to €1.314B, EBITDA margin 23%, strong outlook despite FX and supply risks.ATS
Q3 20263 Feb 2026 - Adjusted EBITDA margin rose to 27.6% despite revenue decline and net loss.ATS
Q1 20252 Feb 2026 - Stable revenue, margin gains, and Ansan sale boost liquidity amid ongoing market pressure.ATS
Q3 20259 Jan 2026 - Revenue, EBITDA, and cash flow improved, but FX and supply chain risks persist.ATS
Q2 202616 Dec 2025 - Revenue up 14.2% year-over-year, but net loss widened on FX and ramp-up costs.ATS
Q1 202616 Nov 2025